296 related articles for article (PubMed ID: 27478959)
1. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model.
Garg NK; Singh B; Tyagi RK; Sharma G; Katare OP
Colloids Surf B Biointerfaces; 2016 Nov; 147():17-24. PubMed ID: 27478959
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery.
Lee SW; Kim JH; Park MC; Park YB; Chae WJ; Morio T; Lee DH; Yang SH; Lee SK; Lee SK; Lee SK
Biomaterials; 2012 Feb; 33(5):1563-72. PubMed ID: 22098778
[TBL] [Abstract][Full Text] [Related]
5. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model.
Zeb A; Qureshi OS; Yu CH; Akram M; Kim HS; Kim MS; Kang JH; Majid A; Chang SY; Bae ON; Kim JK
Int J Pharm; 2017 Jun; 525(1):92-100. PubMed ID: 28428089
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.
Agrawal YO; Mahajan UB; Mahajan HS; Ojha S
Int J Nanomedicine; 2020; 15():4763-4778. PubMed ID: 32753865
[TBL] [Abstract][Full Text] [Related]
8. Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model.
Haloi P; Lokesh BS; Chawla S; Konkimalla VB
Drug Deliv; 2023 Dec; 30(1):2184307. PubMed ID: 36852696
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
[TBL] [Abstract][Full Text] [Related]
11. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
13. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
14. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
[TBL] [Abstract][Full Text] [Related]
15. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
16. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
Sun Y; Yao Y; Ding CZ
Int Immunopharmacol; 2014 Jan; 18(1):135-41. PubMed ID: 24287449
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate.
Mirchandani Y; Patravale VB; Brijesh S
Nanomedicine (Lond); 2022 Jul; 17(16):1099-1114. PubMed ID: 36178114
[TBL] [Abstract][Full Text] [Related]
18. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
20. Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine.
Guo T; Cheng N; Zhao J; Hou X; Zhang Y; Feng N
Int J Pharm; 2019 Dec; 572():118741. PubMed ID: 31705974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]